Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hernando-Calvo, Alberto
409  Ergebnisse:
Personensuche X
?
1

Intratumoral therapies in head and neck squamous cell carci..:

Jiménez-Labaig, Pablo ; Rullan, Antonio ; Braña, Irene...
Cancer Treatment Reviews.  127 (2024)  - p. 102746 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A Phase II, Open-Label, Randomized Trial of Durvalumab With..:

Hernando-Calvo, Alberto ; Han, Ming ; Ayodele, Olubukola...
Clinical Colorectal Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

A systematic review of antibody-drug conjugates and bispeci..:

Jiménez-Labaig, Pablo ; Rullan, Antonio ; Hernando-Calvo, Alberto...
Cancer Treatment Reviews.  128 (2024)  - p. 102772 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Agnostic drug development revisited:

Hernando-Calvo, Alberto ; Rossi, Alice ; Vieito, Maria..
Cancer Treatment Reviews.  128 (2024)  - p. 102747 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Impact on costs and outcomes of multi-gene panel testing fo..:

Hernando-Calvo, Alberto ; Nguyen, Paul ; Bedard, Philippe L....
eClinicalMedicine.  69 (2024)  - p. 102443 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Patient-Centric Approaches for Phase I Combination Trials C..:

Hernando-Calvo, Alberto ; Garralda, Elena
Cancer Discovery.  13 (2023)  8 - p. 1762-1764 , 2023
Link: https://doi.org/10.1158/..
 
?
7

A pan-cancer clinical platform to predict immunotherapy out..:

Hernando-Calvo, Alberto ; Vila-Casadesús, Maria ; Bareche, Yacine...
Med.  4 (2023)  10 - p. 710-727.e5 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Nutritional status associates with immunotherapy clinical o..:

Hernando-Calvo, Alberto ; Mirallas, Oriol ; Marmolejo, David...
Oral Oncology.  140 (2023)  - p. 106364 , 2023
Link: https://doi.org/10.1016/..
 
?
9

A risk stratification model for toxicities in phase 1 immun..:

Hernando-Calvo, Alberto ; Salawu, Abdulazeez ; Chen, Rachel Y....
European Journal of Cancer.  175 (2022)  - p. 11-18 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Response to "Analysis of the association between prospectiv..:

Villacampa, Guillermo ; Hernando-Calvo, Alberto ; Berché, Roger...
Cancer Treatment Reviews.  111 (2022)  - p. 102465 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Impact of pharmacodynamic biomarkers in immuno-oncology pha..:

Salawu, Abdulazeez ; Hernando-Calvo, Alberto ; Chen, Rachel Y....
European Journal of Cancer.  173 (2022)  - p. 167-177 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Phase I prognostic online (PIPO): A web tool to improve pat..:

Matos, Ignacio ; Villacampa, Guillermo ; Hierro, Cinta...
European Journal of Cancer.  155 (2021)  - p. 168-178 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Novel classes of immunotherapy for breast cancer:

Hernando-Calvo, Alberto ; Cescon, David W. ; Bedard, Philippe L.
Breast Cancer Research and Treatment.  191 (2021)  1 - p. 15-29 , 2021
Link: https://doi.org/10.1007/..
 
?
14

A pan-cancer clinical platform to predict immunotherapy out..:

Bareche, Yacine ; Abbas-Aghababazadeh, Farnoosh ; Lo Giacco, Deborah...
Med;4(10).  , 2023
Link: https://hdl.handle.net/1..
 
?
15

Patient-Centric Approaches for Phase I Combination Trials C..:

Hernando-Calvo, Alberto ; GARRALDA, Elena
Cancer Discovery;13(8).  , 2023
Link: https://hdl.handle.net/1..
 
1-15